BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 23583545)

  • 1. Evaluation of sequence ambiguities of the HIV-1 pol gene as a method to identify recent HIV-1 infection in transmitted drug resistance surveys.
    Andersson E; Shao W; Bontell I; Cham F; Cuong do D; Wondwossen A; Morris L; Hunt G; Sönnerborg A; Bertagnolio S; Maldarelli F; Jordan MR
    Infect Genet Evol; 2013 Aug; 18():125-31. PubMed ID: 23583545
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequence ambiguity determined from routine pol sequencing is a reliable tool for real-time surveillance of HIV incidence trends.
    Lunar MM; Židovec Lepej S; Poljak M
    Infect Genet Evol; 2019 Apr; 69():146-152. PubMed ID: 30682549
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of transmitted antiretroviral resistance and distribution of HIV-1 subtypes among patients with recent infection in Catalonia (Spain) between 2003 and 2005.
    Romero A; Sued O; Puig T; Esteve A; Pumarola T; Casabona J; González V; Matas L; Tural C; Rodrigo I; Margall N; Domingo P; Casanova A; Ferrer E; Caballero E; Ribera E; Farré J; Puig T; Amengual MJ; Navarro G; Prat JM; Masabeu A; Simó JM; Villaverde CA; Barrufet P; Sauca MG; Ortin X; Ortí A; Navarro R; Euras JM; Vilaró J; Villà MC; Montull S; Vilanova C; Pujol F; Díaz O; Miró JM;
    Enferm Infecc Microbiol Clin; 2011; 29(7):482-9. PubMed ID: 21543135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A population-based approach to determine the prevalence of transmitted drug-resistant HIV among recent versus established HIV infections: results from the Canadian HIV strain and drug resistance surveillance program.
    Jayaraman GC; Archibald CP; Kim J; Rekart ML; Singh AE; Harmen S; Wood M; Sandstrom P
    J Acquir Immune Defic Syndr; 2006 May; 42(1):86-90. PubMed ID: 16763495
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of ambiguous base calls in HIV-1 pol population sequences as a biomarker for identification of recent infections in HIV-1 incidence studies.
    Meixenberger K; Hauser A; Jansen K; Yousef KP; Fiedler S; von Kleist M; Norley S; Somogyi S; Hamouda O; Bannert N; Bartmeyer B; Kücherer C
    J Clin Microbiol; 2014 Aug; 52(8):2977-83. PubMed ID: 24920768
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Increase in HIV-1-transmitted drug resistance among ART-naïve youths at the China-Myanmar border during 2009 ~ 2017.
    Ding Y; Chen M; Wang J; Yang Y; Feng Y; Wang L; Duan S; Lin Q; Xing H; Ma Y; Han M; Ma L
    BMC Infect Dis; 2021 Jan; 21(1):93. PubMed ID: 33478415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. HIV-1 genetic diversity and transmitted drug resistance frequency among Iranian treatment-naive, sexually infected individuals.
    Vahabpour R; Bokharaei-Salim F; Kalantari S; Garshasbi S; Monavari SH; Esghaei M; Memarnejadian A; Fakhim A; Keyvani H
    Arch Virol; 2017 Jun; 162(6):1477-1485. PubMed ID: 28181034
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of two measures of HIV diversity in multi-assay algorithms for HIV incidence estimation.
    Cousins MM; Konikoff J; Sabin D; Khaki L; Longosz AF; Laeyendecker O; Celum C; Buchbinder SP; Seage GR; Kirk GD; Moore RD; Mehta SH; Margolick JB; Brown J; Mayer KH; Kobin BA; Wheeler D; Justman JE; Hodder SL; Quinn TC; Brookmeyer R; Eshleman SH
    PLoS One; 2014; 9(6):e101043. PubMed ID: 24968135
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incident and long-term HIV-1 infection among pregnant women in Brazil: Transmitted drug resistance and mother-to-child transmission.
    Lima YA; Cardoso LP; Reis MN; Stefani MM
    J Med Virol; 2016 Nov; 88(11):1936-43. PubMed ID: 27037910
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surveillance of HIV-1 pol transmitted drug resistance in acutely and recently infected antiretroviral drug-naïve persons in rural western Kenya.
    Onywera H; Maman D; Inzaule S; Auma E; Were K; Fredrick H; Owiti P; Opollo V; Etard JF; Mukui I; Kim AA; Zeh C
    PLoS One; 2017; 12(2):e0171124. PubMed ID: 28178281
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phylogenetic investigation of transmission pathways of drug-resistant HIV-1 utilizing pol sequences derived from resistance genotyping.
    Kaye M; Chibo D; Birch C
    J Acquir Immune Defic Syndr; 2008 Sep; 49(1):9-16. PubMed ID: 18667928
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Analysis of partial pol and env sequences indicates a high prevalence of HIV type 1 recombinant strains circulating in Gabon.
    Pandrea I; Robertson DL; Onanga R; Gao F; Makuwa M; Ngari P; Bedjabaga I; Roques P; Simon F; Apetrei C
    AIDS Res Hum Retroviruses; 2002 Oct; 18(15):1103-16. PubMed ID: 12396449
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Genetics and the Incidence of Transmitted Drug Resistance Among Pre-Treatment HIV-1 Infected Patients in the Eastern Cape, South Africa.
    Digban TO; Iweriebor BC; Obi LC; Nwodo U; Okoh AI
    Curr HIV Res; 2019; 17(5):335-342. PubMed ID: 31584370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic characterization of HIV-1 strains in Togo reveals a high genetic complexity and genotypic drug-resistance mutations in ARV naive patients.
    Yaotsè DA; Nicole V; Roch NF; Mireille PD; Eric D; Martine P
    Infect Genet Evol; 2009 Jul; 9(4):646-52. PubMed ID: 19460333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular epidemiological analysis of env and pol sequences in newly diagnosed HIV type 1-infected, untreated patients in Hungary.
    Mezei M; Ay E; Koroknai A; Tóth R; Balázs A; Bakos A; Gyori Z; Bánáti F; Marschalkó M; Kárpáti S; Minárovits J
    AIDS Res Hum Retroviruses; 2011 Nov; 27(11):1243-7. PubMed ID: 21453184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular characterization of ambiguous mutations in HIV-1 polymerase gene: implications for monitoring HIV infection status and drug resistance.
    Zheng DP; Rodrigues M; Bile E; Nguyen DB; Diallo K; DeVos JR; Nkengasong JN; Yang C
    PLoS One; 2013; 8(10):e77649. PubMed ID: 24147046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic diversity as a marker for timing infection in HIV-infected patients: evaluation of a 6-month window and comparison with BED.
    Ragonnet-Cronin M; Aris-Brosou S; Joanisse I; Merks H; Vallée D; Caminiti K; Rekart M; Krajden M; Cook D; Kim J; Malloch L; Sandstrom P; Brooks J
    J Infect Dis; 2012 Sep; 206(5):756-64. PubMed ID: 22826337
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular Epidemiology and Transmission Dynamics of Recent and Long-Term HIV-1 Infections in Rural Western Kenya.
    Zeh C; Inzaule SC; Ondoa P; Nafisa LG; Kasembeli A; Otieno F; Vandenhoudt H; Amornkul PN; Mills LA; Nkengasong JN
    PLoS One; 2016; 11(2):e0147436. PubMed ID: 26871567
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Threshold survey evaluating transmitted HIV drug resistance among public antenatal clinic clients in Addis Ababa, Ethiopia.
    Abegaz WE; Grossman Z; Wolday D; Ram D; Kaplan J; Sibide K; Wuhib T; Ismael S; Nkengasong J; Mekonen T; Berhanu H; Messele T; Lulseged S; Maayan S; Mengistu Y
    Antivir Ther; 2008; 13 Suppl 2():89-94. PubMed ID: 18575196
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimization of a low cost and broadly sensitive genotyping assay for HIV-1 drug resistance surveillance and monitoring in resource-limited settings.
    Zhou Z; Wagar N; DeVos JR; Rottinghaus E; Diallo K; Nguyen DB; Bassey O; Ugbena R; Wadonda-Kabondo N; McConnell MS; Zulu I; Chilima B; Nkengasong J; Yang C
    PLoS One; 2011; 6(11):e28184. PubMed ID: 22132237
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.